Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Regeneron Pharmaceuticals Cash on Hand 2010-2025 | REGN

Regeneron Pharmaceuticals cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Regeneron Pharmaceuticals cash on hand for the quarter ending March 31, 2025 was $8.349B, a 20.63% decline year-over-year.
  • Regeneron Pharmaceuticals cash on hand for 2024 was $9.013B, a 16.9% decline from 2023.
  • Regeneron Pharmaceuticals cash on hand for 2023 was $10.845B, a 40.07% increase from 2022.
  • Regeneron Pharmaceuticals cash on hand for 2022 was $7.742B, a 35.96% increase from 2021.
  
Regeneron Pharmaceuticals Annual Cash on Hand
(Millions of US $)
2024 $9,013
2023 $10,845
2022 $7,742
2021 $5,695
2020 $3,587
2019 $3,214
2018 $2,810
2017 $1,410
2016 $1,039
2015 $1,045
2014 $900
2013 $694
2012 $308
2011 $527
2010 $249
2009 $341
Regeneron Pharmaceuticals Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $8,349
2024-12-31 $9,013
2024-09-30 $9,797
2024-06-30 $9,809
2024-03-31 $10,520
2023-12-31 $10,845
2023-09-30 $9,914
2023-06-30 $8,928
2023-03-31 $8,960
2022-12-31 $7,742
2022-09-30 $7,022
2022-06-30 $7,566
2022-03-31 $7,051
2021-12-31 $5,695
2021-09-30 $5,788
2021-06-30 $3,911
2021-03-31 $3,504
2020-12-31 $3,587
2020-09-30 $3,026
2020-06-30 $3,144
2020-03-31 $4,003
2019-12-31 $3,214
2019-09-30 $2,878
2019-06-30 $2,670
2019-03-31 $3,232
2018-12-31 $2,810
2018-09-30 $2,192
2018-06-30 $1,684
2018-03-31 $1,625
2017-12-31 $1,410
2017-09-30 $1,379
2017-06-30 $1,268
2017-03-31 $1,307
2016-12-31 $1,039
2016-09-30 $1,408
2016-06-30 $1,045
2016-03-31 $849
2015-12-31 $1,045
2015-09-30 $896
2015-06-30 $604
2015-03-31 $742
2014-12-31 $900
2014-09-30 $1,042
2014-06-30 $817
2014-03-31 $648
2013-12-31 $694
2013-09-30 $445
2013-06-30 $538
2013-03-31 $308
2012-12-31 $308
2012-09-30 $263
2012-06-30 $301
2012-03-31 $432
2011-12-31 $527
2011-09-30 $245
2011-06-30 $310
2011-03-31 $226
2010-12-31 $249
2010-09-30 $479
2010-06-30 $306
2010-03-31 $304
2009-12-31 $341
2009-09-30 $380
2009-06-30 $392
2009-03-31 $416
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $55.991B $14.202B
Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also developed an antibody cocktail for COVID-19, REGEN-COV. REGEN-COV is a cocktail of two monoclonal antibodies and was designed specifically to block the infectivity of SARS-CoV-2, the virus that causes COVID-19. Regeneron has a collaboration agreement with Roche for the same. While Regeneron has co-developed Eylea with Bayer's HealthCare unit, Praluent was co-developed with Sanofi. Regeneron collaborated with Bayer for the joint development and commercialization of co-formulated combinations of Eylea, rinucumab and nesvacumab for the treatment of ocular diseases or disorders outside the United States.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $228.688B 17.07
Amgen (AMGN) United States $156.908B 14.06
Gilead Sciences (GILD) United States $135.961B 14.12
Vertex Pharmaceuticals (VRTX) United States $116.185B 0.00
Bristol Myers Squibb (BMY) United States $102.080B 6.83
GSK (GSK) United Kingdom $85.304B 10.20
CSL (CSLLY) Australia $75.905B 0.00
Alnylam Pharmaceuticals (ALNY) United States $38.931B 0.00
Argenex SE (ARGX) Netherlands $35.107B 95.83
BioNTech SE (BNTX) Germany $25.352B 0.00
Biogen (BIIB) United States $19.497B 8.41
Royalty Pharma (RPRX) United States $19.144B 8.09
Insmed (INSM) United States $17.846B 0.00
Genmab (GNMSF) Denmark $14.821B 15.15
Genmab (GMAB) Denmark $14.511B 16.28
Illumina (ILMN) United States $13.858B 26.29
Incyte (INCY) United States $13.327B 101.25
Swedish Orphan Biovitrum (BIOVF) Sweden $11.389B 29.08
Exelixis (EXEL) United States $11.298B 19.18
BioMarin Pharmaceutical (BMRN) United States $10.962B 17.81
Moderna (MRNA) United States $10.732B 0.00
Exact Sciences (EXAS) United States $10.500B 0.00
Ascendis Pharma (ASND) Denmark $10.491B 0.00
QIAGEN (QGEN) Netherlands $10.385B 20.21
Blueprint Medicines (BPMC) United States $8.263B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $8.102B 0.00
Bio-Techne Corp (TECH) United States $8.080B 30.14
Roivant Sciences (ROIV) United Kingdom $7.668B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.666B 0.00
Revolution Medicines (RVMD) United States $7.598B 0.00
Repligen (RGEN) United States $7.416B 83.02
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Legend Biotech (LEGN) United States $6.724B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.686B 6.57
Halozyme Therapeutics (HALO) United States $6.635B 12.70
TG Therapeutics (TGTX) United States $6.083B 159.67
Guardant Health (GH) United States $6.074B 0.00
Telix Pharmaceuticals (TLX) Australia $5.761B 0.00
Nuvalent (NUVL) United States $5.523B 0.00
Axsome Therapeutics (AXSM) United States $5.321B 0.00
Zealand Pharma (ZLDPF) Denmark $5.265B 0.00
ADMA Biologics Inc (ADMA) United States $5.221B 39.05
Alkermes (ALKS) Ireland $5.145B 13.81
Vaxcyte (PCVX) United States $4.572B 0.00
Zai Lab (ZLAB) China $4.568B 0.00
Akero Therapeutics (AKRO) United States $4.221B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.125B 0.00
Krystal Biotech (KRYS) United States $4.035B 31.10
PTC Therapeutics (PTCT) United States $4.028B 7.01
Cytokinetics (CYTK) United States $3.954B 0.00
Avidity Biosciences (RNA) United States $3.858B 0.00
Merus (MRUS) Netherlands $3.810B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.732B 32.79
Sarepta Therapeutics (SRPT) United States $3.716B 0.00
Arcellx (ACLX) United States $3.646B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.586B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.546B 0.00
SpringWorks Therapeutics (SWTX) United States $3.523B 0.00
Metsera (MTSR) United States $3.473B 0.00
Protagonist Therapeutics (PTGX) United States $3.430B 73.79
Viking Therapeutics (VKTX) United States $3.251B 0.00
Kymera Therapeutics (KYMR) United States $3.151B 0.00
Scholar Rock Holding (SRRK) United States $3.134B 0.00
Alvotech (ALVO) Luxembourg $3.048B 17.43
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.990B 0.00
ImmunityBio (IBRX) United States $2.860B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.827B 0.00
Immunovant (IMVT) United States $2.760B 0.00
Ascentage Pharma Group - (AAPG) China $2.592B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.475B 0.00
Apellis Pharmaceuticals (APLS) United States $2.422B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.400B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.312B 0.00
Bavarian Nordic (BVNRY) Denmark $2.238B 11.82
Ligand Pharmaceuticals (LGND) United States $2.226B 0.00
Vericel (VCEL) United States $2.224B 1472.67
Denali Therapeutics (DNLI) United States $2.207B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.205B 0.00
Twist Bioscience (TWST) United States $2.106B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.018B 13.41
CG Oncology (CGON) United States $1.996B 0.00
Agios Pharmaceuticals (AGIO) United States $1.993B 0.00
Certara (CERT) United States $1.976B 36.91
Apogee Therapeutics (APGE) United States $1.954B 0.00
Belite Bio (BLTE) United States $1.945B 0.00
NovoCure (NVCR) Jersey $1.935B 0.00
IDEAYA Biosciences (IDYA) United States $1.920B 0.00
Amicus Therapeutics (FOLD) United States $1.891B 204.67
Beam Therapeutics (BEAM) United States $1.799B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.786B 0.00
Disc Medicine (IRON) United States $1.762B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.721B 0.00
Edgewise Therapeutics (EWTX) United States $1.657B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.637B 0.00
Adaptive Biotechnologies (ADPT) United States $1.615B 0.00
Biohaven (BHVN) United States $1.602B 0.00
BGM Group (BGM) China $1.590B 0.00
GRAIL (GRAL) United States $1.578B 0.00
Mesoblast (MESO) Australia $1.517B 0.00
Janux Therapeutics (JANX) United States $1.507B 0.00
89BIO (ETNB) United States $1.466B 0.00
Vera Therapeutics (VERA) United States $1.409B 0.00
ANI Pharmaceuticals (ANIP) United States $1.360B 14.01
Celldex Therapeutics (CLDX) United States $1.356B 0.00
Viridian Therapeutics (VRDN) United States $1.313B 0.00
Structure Therapeutics (GPCR) United States $1.303B 0.00
Travere Therapeutics (TVTX) United States $1.289B 0.00
Anbio Biotechnology (NNNN) Germany $1.248B 0.00
Dynavax Technologies (DVAX) United States $1.222B 72.71
Liquidia Technologies (LQDA) United States $1.208B 0.00
MannKind (MNKD) United States $1.179B 24.25
Novavax (NVAX) United States $1.148B 2.68
Pacira BioSciences (PCRX) United States $1.127B 10.72
Niagen Bioscience (NAGE) United States $1.108B 156.33
WAVE Life Sciences (WVE) Singapore $1.108B 0.00
Spyre Therapeutics (SYRE) United States $1.085B 0.00
Mineralys Therapeutics (MLYS) United States $1.013B 0.00
NeoGenomics (NEO) United States $1.008B 0.00
CorMedix Inc (CRMD) United States $0.990B 66.32
Geron (GERN) United States $0.981B 0.00
AbCellera Biologics (ABCL) Canada $0.964B 0.00
Nurix Therapeutics (NRIX) United States $0.963B 0.00
Arcus Biosciences (RCUS) United States $0.961B 0.00
MiMedx (MDXG) United States $0.948B 22.93
Syndax Pharmaceuticals (SNDX) United States $0.938B 0.00
CureVac (CVAC) Germany $0.913B 4.42
Praxis Precision Medicines (PRAX) United States $0.908B 0.00
Zymeworks (ZYME) United States $0.896B 0.00
Pharvaris (PHVS) Netherlands $0.892B 0.00
UniQure (QURE) Netherlands $0.888B 0.00
Intellia Therapeutics (NTLA) United States $0.867B 0.00
Oculis Holding AG (OCS) Switzerland $0.857B 0.00
LENZ Therapeutics (LENZ) United States $0.844B 0.00
Cogent Biosciences (COGT) United States $0.827B 0.00
Immunome (IMNM) United States $0.826B 0.00
ArriVent BioPharma (AVBP) United States $0.797B 0.00
Pharming Group (PHGUF) Netherlands $0.795B 0.00
Gyre Therapeutics (GYRE) United States $0.791B 211.00
Pharming Group (PHAR) Netherlands $0.787B 0.00
Sionna Therapeutics (SION) United States $0.762B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
Replimune (REPL) United States $0.754B 0.00
Nuvation Bio (NUVB) United States $0.749B 0.00
Iovance Biotherapeutics (IOVA) United States $0.748B 0.00
Trevi Therapeutics (TRVI) United States $0.733B 0.00
Vir Biotechnology (VIR) United States $0.726B 0.00
Immatics (IMTX) Germany $0.724B 0.00
GH Research (GHRS) Ireland $0.717B 0.00
Anavex Life Sciences (AVXL) United States $0.700B 0.00
AnaptysBio (ANAB) United States $0.693B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.684B 0.00
Arbutus Biopharma (ABUS) United States $0.670B 0.00
Oric Pharmaceuticals (ORIC) United States $0.668B 0.00
Bicara Therapeutics (BCAX) United States $0.648B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.631B 0.00
Upstream Bio (UPB) United States $0.628B 0.00
Stoke Therapeutics (STOK) United States $0.628B 14.56
Sana Biotechnology (SANA) United States $0.609B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.607B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.606B 0.00
Kura Oncology (KURA) United States $0.599B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.596B 0.00
Dianthus Therapeutics (DNTH) United States $0.583B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.572B 0.00
Keros Therapeutics (KROS) United States $0.560B 0.00
Arvinas (ARVN) United States $0.560B 0.00
Maze Therapeutics (MAZE) United States $0.560B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.559B 0.00
Tyra Biosciences (TYRA) United States $0.540B 0.00
Castle Biosciences (CSTL) United States $0.532B 36.16
Cullinan Therapeutics (CGEM) United States $0.530B 0.00
Opthea (OPT) Australia $0.525B 0.00
MeiraGTx Holdings (MGTX) United States $0.521B 0.00
Tango Therapeutics (TNGX) United States $0.514B 0.00
REGENXBIO (RGNX) United States $0.512B 0.00
Zenas BioPharma (ZBIO) United States $0.507B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.494B 0.00
Fortrea Holdings (FTRE) United States $0.491B 13.57
ATyr Pharma (ATYR) United States $0.480B 0.00
Myriad Genetics (MYGN) United States $0.477B 0.00
Celcuity (CELC) United States $0.473B 0.00
Abivax SA (ABVX) France $0.471B 0.00
PureTech Health (PRTC) United States $0.462B 0.00
Septerna (SEPN) United States $0.458B 0.00
Precigen (PGEN) United States $0.443B 0.00
Rapport Therapeutics (RAPP) United States $0.442B 0.00
Tectonic Therapeutic (TECX) United States $0.439B 0.00
Cytek Biosciences (CTKB) United States $0.436B 0.00
Benitec Biopharma (BNTC) United States $0.435B 0.00
Erasca (ERAS) United States $0.431B 0.00
Sage Therapeutics (SAGE) United States $0.424B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.421B 0.00
Eton Pharmaceuticals (ETON) United States $0.405B 0.00
Kamada (KMDA) Israel $0.400B 23.97
Humacyte (HUMA) United States $0.394B 0.00
Absci (ABSI) United States $0.384B 0.00
ITeos Therapeutics (ITOS) United States $0.383B 0.00
Northwest Biotherapeutics (NWBO) United States $0.381B 0.00
Rezolute (RZLT) United States $0.372B 0.00
Checkpoint Therapeutics (CKPT) United States $0.371B 0.00
Fulcrum Therapeutics (FULC) United States $0.369B 0.00
Vigil Neuroscience (VIGL) United States $0.367B 0.00
MBX Biosciences (MBX) United States $0.366B 0.00
Emergent Biosolutions (EBS) United States $0.362B 0.00
Terns Pharmaceuticals (TERN) United States $0.358B 0.00
Solid Biosciences (SLDB) United States $0.357B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.350B 0.00
Ocugen (OCGN) United States $0.339B 0.00
Inventiva S.A (IVA) France $0.339B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.337B 0.00
Urogen Pharma (URGN) United States $0.337B 0.00
Compass Therapeutics (CMPX) United States $0.336B 0.00
Aura Biosciences (AURA) United States $0.333B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.328B 0.00
Verastem (VSTM) United States $0.328B 0.00
Astria Therapeutics (ATXS) United States $0.327B 0.00
Cidara Therapeutics (CDTX) United States $0.325B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.324B 0.00
Alpha Teknova (TKNO) United States $0.319B 0.00
Abeona Therapeutics (ABEO) United States $0.318B 0.00
Allogene Therapeutics (ALLO) United States $0.317B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.311B 63.12
Corvus Pharmaceuticals (CRVS) United States $0.307B 0.00
XOMA Royalty (XOMA) United States $0.300B 0.00
Entrada Therapeutics (TRDA) United States $0.300B 9.75
Neurogene (NGNE) United States $0.298B 0.00
Gossamer Bio (GOSS) United States $0.293B 0.00
Palvella Therapeutics (PVLA) United States $0.280B 0.00
Olema Pharmaceuticals (OLMA) United States $0.279B 0.00
Annexon (ANNX) United States $0.276B 0.00
Prothena (PRTA) Ireland $0.275B 0.00
Amarin (AMRN) Ireland $0.274B 0.00
Candel Therapeutics (CADL) United States $0.274B 0.00
Atea Pharmaceuticals (AVIR) United States $0.272B 0.00
Cartesian Therapeutics (RNAC) United States $0.270B 0.00
Prima BioMed (IMMP) Australia $0.270B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.270B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Cardiff Oncology (CRDF) United States $0.257B 0.00
Inozyme Pharma (INZY) United States $0.256B 0.00
Foghorn Therapeutics (FHTX) United States $0.255B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.254B 0.00
Lifecore Biomedical (LFCR) United States $0.250B 0.00
Semper Paratus Acquisition (TVGN) United States $0.246B 0.00
Tvardi Therapeutics (TVRD) United States $0.245B 0.00
Aardvark Therapeutics (AARD) United States $0.245B 0.00
MaxCyte (MXCT) United States $0.245B 0.00
Instil Bio (TIL) United States $0.240B 0.00
DBV Technologies S.A (DBVT) France $0.239B 0.00
Third Harmonic Bio (THRD) United States $0.237B 0.00
BioStem Technologies (BSEM) $0.233B 9.50
ACELYRIN, INC (SLRN) United States $0.229B 0.00
CytomX Therapeutics (CTMX) United States $0.227B 5.88
Adherex Technologies (FENC) United States $0.226B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.223B 0.00
Design Therapeutics (DSGN) United States $0.221B 0.00
ScPharmaceuticals (SCPH) United States $0.215B 0.00
Adocia (ADOCY) France $0.213B 0.00
AC Immune (ACIU) Switzerland $0.213B 0.00
Kodiak Sciences (KOD) United States $0.213B 0.00
Inhibrx Biosciences (INBX) United States $0.213B 0.13
Monopar Therapeutics (MNPR) United States $0.212B 0.00
GENFIT S.A (GNFT) France $0.210B 0.00
CARGO Therapeutics (CRGX) United States $0.207B 0.00
I-Mab (IMAB) United States $0.203B 0.00
Prime Medicine (PRME) United States $0.201B 0.00
Codexis (CDXS) United States $0.196B 0.00
Bright Minds Biosciences (DRUG) United States $0.195B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.191B 0.00
Sagimet Biosciences (SGMT) United States $0.190B 0.00
Voyager Therapeutics (VYGR) United States $0.187B 0.00
INmune Bio (INMB) United States $0.186B 0.00
Innate Pharma S.A (IPHA) France $0.185B 0.00
Nuvectis Pharma (NVCT) United States $0.184B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.180B 0.00
Fate Therapeutics (FATE) United States $0.178B 0.00
Puma Biotechnology (PBYI) United States $0.176B 4.60
Ventyx Biosciences (VTYX) United States $0.174B 0.00
DiaMedica Therapeutics (DMAC) United States $0.173B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.171B 0.00
Actuate Therapeutics (ACTU) United States $0.170B 0.00
Editas Medicine (EDIT) United States $0.170B 0.00
EnGene Holdings (ENGN) Canada $0.164B 0.00
Alector (ALEC) United States $0.163B 0.00
Anika Therapeutics (ANIK) United States $0.162B 0.00
BioAge Labs (BIOA) United States $0.159B 0.00
Spero Therapeutics (SPRO) United States $0.157B 0.00
Alumis (ALMS) United States $0.155B 0.00
Compugen (CGEN) Israel $0.155B 0.00
Alpha Cognition (ACOG) Canada $0.154B 0.00
Galena Biopharma (SLS) United States $0.150B 0.00
23andMe Holding (MEHCQ) United States $0.149B 0.00
Neumora Therapeutics (NMRA) United States $0.149B 0.00
Molecular Partners AG (MOLN) Switzerland $0.146B 0.00
Rapt Therapeutics (RAPT) United States $0.146B 0.00
Kyverna Therapeutics (KYTX) United States $0.143B 0.00
Nkarta (NKTX) United States $0.142B 0.00
Agenus (AGEN) United States $0.141B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.141B 0.00
Black Diamond Therapeutics (BDTX) United States $0.135B 39.50
Seer (SEER) United States $0.129B 0.00
Greenwich LifeSciences (GLSI) United States $0.129B 0.00
Elicio Therapeutics (ELTX) United States $0.127B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.121B 0.00
Sangamo Therapeutics (SGMO) United States $0.121B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.121B 0.00
BioHarvest Sciences (BHST) Canada $0.120B 0.00
Contineum Therapeutics (CTNM) United States $0.118B 0.00
BeyondSpring (BYSI) United States $0.117B 0.00
Theratechnologies (THTX) Canada $0.117B 0.00
TuHURA Biosciences (HURA) United States $0.116B 0.00
EXoZymes (EXOZ) United States $0.110B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.110B 0.00
Caribou Biosciences (CRBU) United States $0.110B 0.00
C4 Therapeutics (CCCC) United States $0.108B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.106B 0.00
Invivyd (IVVD) United States $0.104B 0.00
Tenaya Therapeutics (TNYA) United States $0.103B 0.00
Citius Oncology (CTOR) United States $0.102B 0.00
Genelux (GNLX) United States $0.100B 0.00
IO Biotech (IOBT) Denmark $0.099B 0.00
HilleVax (HLVX) United States $0.098B 0.00
Entera Bio (ENTX) Israel $0.095B 0.00
Whitehawk Therapeutics (WHWK) United States $0.094B 0.00
Coya Therapeutics (COYA) United States $0.094B 0.00
Biomea Fusion (BMEA) United States $0.094B 0.00
Coherus Oncology (CHRS) United States $0.093B 0.00
Adagene (ADAG) China $0.093B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.093B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.092B 0.00
Nautilus Biotechnology (NAUT) United States $0.091B 0.00
TScan Therapeutics (TCRX) United States $0.091B 0.00
Pliant Therapeutics (PLRX) United States $0.090B 0.00
Cabaletta Bio (CABA) United States $0.089B 0.00
Zura Bio (ZURA) United States $0.086B 0.00
XBiotech (XBIT) United States $0.086B 0.00
Climb Bio (CLYM) United States $0.085B 0.00
Jasper Therapeutics (JSPR) United States $0.084B 0.00
Immunic (IMUX) United States $0.083B 0.00
Forte Biosciences (FBRX) United States $0.083B 0.00
Elutia (ELUT) United States $0.083B 0.00
PDS Biotechnology (PDSB) United States $0.080B 0.00
Cellectis S.A (CLLS) France $0.079B 0.00
OKYO Pharma (OKYO) $0.079B 0.00
Inovio Pharmaceuticals (INO) United States $0.078B 0.00
Immuneering (IMRX) United States $0.076B 0.00
IGM Biosciences (IGMS) United States $0.076B 0.00
TELA Bio (TELA) United States $0.074B 0.00
Senti Biosciences (SNTI) United States $0.073B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.072B 0.00
Seres Therapeutics (MCRB) United States $0.070B 0.00
Sutro Biopharma (STRO) United States $0.070B 0.00
Genenta Science S.p.A (GNTA) Italy $0.070B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.069B 0.00
VistaGen Therapeutics (VTGN) United States $0.068B 0.00
Immix Biopharma (IMMX) United States $0.068B 0.00
Alto Neuroscience (ANRO) United States $0.068B 0.00
Ikena Oncology (IKNA) United States $0.068B 0.00
Skye Bioscience (SKYE) United States $0.067B 0.00
MediciNova (MNOV) United States $0.067B 0.00
Akoya Biosciences (AKYA) United States $0.066B 0.00
CervoMed (CRVO) United States $0.065B 0.00
Adicet Bio (ACET) United States $0.065B 0.00
Clearside Biomedical (CLSD) United States $0.063B 0.00
Fortress Biotech (FBIO) United States $0.062B 0.00
Repare Therapeutics (RPTX) Canada $0.062B 0.00
Adlai Nortye (ANL) Cayman Islands $0.062B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Oncobiologics (OTLK) United States $0.060B 0.00
Renovaro (RENB) United States $0.059B 0.00
Opus Genetics (IRD) United States $0.059B 0.00
Exicure (XCUR) United States $0.059B 0.00
Quince Therapeutics (QNCX) United States $0.057B 0.00
Precision BioSciences (DTIL) United States $0.056B 0.00
InflaRx (IFRX) Germany $0.056B 0.00
Werewolf Therapeutics (HOWL) United States $0.055B 0.00
Annovis Bio (ANVS) United States $0.055B 0.00
Kalaris Therapeutics (KLRS) United States $0.054B 0.00
Adverum Biotechnologies (ADVM) United States $0.054B 0.00
ZIVO Bioscience (ZIVO) United States $0.053B 0.00
Kronos Bio (KRON) United States $0.053B 0.00
Atara Biotherapeutics (ATRA) United States $0.053B 0.00
VTv Therapeutics (VTVT) United States $0.053B 0.00
Applied Therapeutics (APLT) United States $0.053B 0.00
Shattuck Labs (STTK) United States $0.052B 0.00
RenovoRx (RNXT) United States $0.050B 0.00
Oncolytics Biotech (ONCY) Canada $0.050B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
Aligos Therapeutics (ALGS) United States $0.048B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
Artiva Biotherapeutics (ARTV) United States $0.048B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.048B 0.00
PepGen (PEPG) United States $0.047B 0.00
Mersana Therapeutics (MRSN) United States $0.047B 0.00
Connect Biopharma Holdings (CNTB) United States $0.046B 0.00
Rein Therapeutics (RNTX) United States $0.043B 0.00
Celularity (CELU) United States $0.043B 0.00
Quantum Biopharma (QNTM) Canada $0.042B 0.00
Alterity Therapeutics - (ATHE) Australia $0.041B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.041B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.040B 0.00
Scilex Holding (SCLX) United States $0.039B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.039B 0.00
OnKure Therapeutics (OKUR) United States $0.038B 0.00
Clene (CLNN) United States $0.038B 0.00
Lantern Pharma (LTRN) United States $0.036B 0.00
Medicus Pharma (MDCX) United States $0.036B 0.00
Estrella Immunopharma (ESLA) United States $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.035B 0.00
Radiopharm Theranostics - (RADX) Australia $0.035B 0.00
Pluri (PLUR) Israel $0.035B 0.00
AN2 Therapeutics (ANTX) United States $0.034B 0.00
Kezar Life Sciences (KZR) United States $0.034B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.034B 0.00
FibroBiologics (FBLG) United States $0.033B 0.00
CAMP4 Therapeutics (CAMP) United States $0.033B 0.00
Rani Therapeutics Holdings (RANI) United States $0.033B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Cadrenal Therapeutics (CVKD) United States $0.030B 0.00
ALX Oncology Holdings (ALXO) United States $0.029B 0.00
Curis (CRIS) United States $0.029B 0.00
Imunon (IMNN) United States $0.029B 0.00
Grace Therapeutics (GRCE) Canada $0.029B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
Passage Bio (PASG) United States $0.029B 0.00
ABVC BioPharma (ABVC) United States $0.028B 0.00
KALA BIO (KALA) United States $0.028B 0.00
Vor Biopharma (VOR) $0.027B 0.00
BioAtla (BCAB) United States $0.027B 0.00
Generation Bio (GBIO) United States $0.026B 0.00
CalciMedica (CALC) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Boundless Bio (BOLD) United States $0.024B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
Ovid Therapeutics (OVID) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.022B 0.00
Gelteq (GELS) Australia $0.022B 0.00
Femasys (FEMY) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.021B 0.00
Q32 Bio (QTTB) United States $0.021B 0.00
Advanced Biomed (ADVB) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.020B 0.00
Longeveron (LGVN) United States $0.020B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.020B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.020B 0.00
Cognition Therapeutics (CGTX) United States $0.020B 0.00
Cingulate (CING) United States $0.020B 0.00
X4 Pharmaceuticals (XFOR) United States $0.019B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
Leap Therapeutics (LPTX) United States $0.018B 0.00
HOOKIPA Pharma (HOOK) United States $0.018B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
GeoVax Labs (GOVX) United States $0.017B 0.00
Beyond Air (XAIR) United States $0.017B 0.00
NextCure (NXTC) United States $0.017B 0.00
IBio (IBIO) United States $0.016B 0.00
Abpro Holdings (ABP) United States $0.015B 0.00
UNITY Biotechnology (UBX) United States $0.015B 0.00
Rallybio (RLYB) United States $0.015B 0.00
MetaVia (MTVA) United States $0.015B 0.00
Synlogic (SYBX) United States $0.014B 0.00
Biorestorative Therapies (BRTX) United States $0.014B 0.00
Equillium (EQ) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Allarity Therapeutics (ALLR) United States $0.013B 0.00
Edesa Biotech (EDSA) Canada $0.013B 0.00
BRIACELL THERAP (BCTX) Canada $0.013B 0.00
Athira Pharma (ATHA) United States $0.013B 0.00
Bolt Biotherapeutics (BOLT) United States $0.013B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.013B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Aytu BioPharma (AYTU) United States $0.012B 0.00
BioCardia (BCDA) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
BioXcel Therapeutics (BTAI) United States $0.011B 0.00
Intensity Therapeutics (INTS) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
Eyenovia (EYEN) United States $0.010B 0.00
Evogene (EVGN) Israel $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
Novogen (KZIA) Australia $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Sensei Biotherapeutics (SNSE) United States $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
IN8bio (INAB) United States $0.008B 0.00
Apollomics (APLM) United States $0.008B 0.00
HCW Biologics (HCWB) United States $0.008B 0.00
Portage Biotech (PRTG) $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.007B 0.00
Synaptogenix (SNPX) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Capstone Holding� (CAPS) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00